Skip to main content

UM School of Medicine Establishes Endowed Professorship in Neurosurgery Through Private Gifts and Matching State Funds

November 13, 2019

Howard M. Eisenberg, MD

Full Endowment of $2.3 Million Includes Funds from Anonymous Donor and Matching Funds from State to Recruit High-Level Neurosurgeon Scientist

University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the UMSOM has been awarded matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, when combined with private philanthropy, will enable UMSOM to establish the Howard M. Eisenberg, MD, Distinguished Professorship in Neurosurgery.

Dr. Eisenberg is recognized as one of the nation’s top neurosurgeons and pre-eminent experts on traumatic brain injury before recently stepping down as Chair of the UMSOM Department of Neurosurgery after more than 25 years of service. The new recruit will foster innovation and discovery in the field of neurosurgical and translational neuroscience research with a focus on applications towards clinical use and potential commercialization to bring new intellectual capital to the state of Maryland.

This year, with private donations from an anonymous donor, combined with state matching funds, the UMSOM will be awarded $2,345,000. As part of its goal to attract and retain top faculty and foster the development of new technologies and therapies, the School requested that the funds be used to establish an endowed professorship to recruit a high-level neurosurgeon-scientist who will continue the legacy of Howard M. Eisenberg, MD.

“Endowed professorships provide our outstanding faculty members with the critical resources they need to sustain and expand the promising research they endeavor to carry out, while at the same time enabling them to launch new initiatives to educate and train future physicians,” said Dean Reece, Executive Vice President for Medical Affairs at UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. “We are so proud to be able to do this in the name of one of our most distinguished faculty members – Howard Eisenberg.”

The E-Nnovation program, which was created as an economic stimulus in 2014, is a special non-lapsing fund designed to help the state’s research universities recruit and retain top scientists and investigators. Under the fund, approximately $8.5 million will be appropriated by the governor each year from fiscal years 2016 through 2021.

“Words cannot express my appreciation of having the honor of my name on this newly endowed chair,” Dr. Eisenberg said. “I am confident that this new position will be filled by a worthy neurosurgeon-scientist who will bring the department at the School of Medicine to new heights.”

As Chair of the Department of Neurosurgery, he led a group of neurosurgeons and scientists in providing innovative programs that result in safer, less intrusive and more effective treatments, particularly for traumatic central nervous system injury, and more recently, for Parkinson’s disease. The research interests of the Department have extended from the mechanisms of traumatic central nervous system injury and stroke, to the biology of brain tumors.

Dr. Eisenberg was also a principal investigator for a pivotal study of Parkinson’s disease. This work has resulted in ground breaking research and a clinical trial on MRI-guided focused ultrasound (FUS) to treat essential tremor and Parkinson’s disease. This research ultimately led the effort for FDA approval of FUS to treat patients with essential tremor.

UMSOM’s Department of Neurosurgery has a proven track record of translating research discoveries from the laboratory to the clinic with successful paths to product commercialization. These efforts have consistently brought new intellectual capital and resources to the state of Maryland. Most recently, the Department, led by Graeme Woodworth, MD, initiated the first United States clinical trial using FUS technology to open the blood brain barrier for therapeutic delivery directly into the brain to combat deadly brain tumors such as glioblastoma.

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 43 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished recipient of the Albert E. Lasker Award in Medical Research.  With an operating budget of more than $1 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for more than 1.2 million patients each year. The School has over 2,500 students, residents, and fellows, and more than $540 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total workforce of nearly 7,000 individuals. The combined School and Medical System (“University of Maryland Medicine”) has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8th highest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu

 

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Thursday, March 28, 2019

    UM School of Medicine Announces Leadership Transition in Department of Neurosurgery

    Dean E Albert Reece, MD, PhD, MBA, announced today that longtime Chair of the Department of Neurosurgery and nationally-recognized neurosurgeon Howard M. Eisenberg, MD, will be stepping down at the end of this academic year as chair after 23 years. He will return to the full-time faculty of the UMSOM Department of Neurosurgery, retaining his title as the R.K. Thompson Professor of Neurosurgery. He will continue his research and his efforts advancing surgical techniques including gamma knife radiosurgery and image-guided focused ultrasound.


    Friday, February 16, 2018

    University of Maryland Medicine Leads Pivotal Study of Focused Ultrasound to Treat Parkinson's Disease

    University of Maryland Medicine (the University of Maryland Medical Center (UMMC) and the University of Maryland School of Medicine (UMSOM)) is leading a phase 3 study to test the safety and efficacy of using MRI-guided focused ultrasound on the brain in order to treat Parkinson’s disease. The pivotal study is the final step before the U.S. Food and Drug Administration (FDA) will consider approving the new technology for widespread use as a nonsurgical treatment option to eliminate key motor symptoms of this common neurological condition.


    Tuesday, August 30, 2016

    New Study Shows Breakthrough Treatment for Essential Tremor Using Focused Ultrasound

    University of Maryland School of Medicine (UM SOM) researchers, along with an international group of investigators, have discovered for the first time that treatment with MRI-guided focused ultrasound can effectively treat patients with essential tremor (ET), a neurological movement disorder that affects an estimated 10 million people in the U.S. The results, which are published in the forthcoming issue of the New England Journal of Medicine, led to recent approval of the treatment by the Food & Drug Administration (FDA),


    Tuesday, March 01, 2016

    UM SOM Appoints Prominent Physician Scientist Dr. Robert W. Buchanan as New Director of the Maryland Psychiatric Research Center

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, along with Bankole Johnson, DSc, MD, MB, ChB, MPhil, Chairman of the UM SOM Department of Psychiatry, announced today that Robert W. Buchanan, MD, has been appointed Director of the Maryland Psychiatric Research Center (MPRC).


    Tuesday, September 01, 2015

    University of Maryland Medicine Tests Novel Treatment for Parkinson's

    University of Maryland Medicine (the University of Maryland Medical Center and the University of Maryland School of Medicine) and its Center for Metabolic Imaging and Image-Guided Therapeutics (CMIT) has begun to use MRI-guided focused ultrasound on a deep structure within the brain related to Parkinson’s disease – the globus pallidus.